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Follow-up Results After Negative Findings
on Unenhanced Hepatic MR Imaging for
Hepatic Metastasis from Rectal Cancer
Objective: To assess the follow-up results after negative findings on unen-
hanced hepatic MR imaging in rectal cancer patients who have undergone locally
curative surgery.
Materials and Methods: From all pertinent imaging reports and medical
records, we selected 255 patients who had negative results on unenhanced
hepatic MR imaging. When selecting patients who had undergone curative resec-
tion, the following patients were excluded from the study: 1) patients in whom
extrahepatic metastases were detected on preoperative staging work-ups, 2)
patients in whom the surgery was judged to be non-curative due to peritoneal
seeding or local aggressiveness. Cases with follow-up periods of less than 18
months were also excluded, as these cases were considered insufficient to con-
firm the negative outcomes. Thus, a total of 149 patients were ultimately enrolled
in our study. The follow-up results of unenhanced MR imagings were assessed
according to the assumption that the newly developed hepatic metastases had
been false-negative lesions on preoperative MR image. 
Results: During a median follow-up period of 29.3 months, 25 hepatic metas-
tases were detected in 13 patients (8.7%), which indicated a negative predictive
value of 91.3%.
Conclusion: Unenhanced hepatic MR imaging provides a high negative pre-
dictive value with regard to the detection of hepatic metastasis in the preoperative
evaluation of rectal cancer. 
epatic metastasis is a prevalent cause of death, even in patients undergo-
ing apparently curative resections for colorectal cancer (1). Previous
studies have shown that the majority of these patients harbor occult liver
metastases, i.e. those which are undetectable by the surgeon upon laparotomy, or  on
conventional pre-operative imaging (2, 3). As surgical resection may offer a better
survival rate and quality of life (4-6), an accurate preoperative assessment of the
presence and distribution of hepatic metastases is vital. 
In several previous studies (7, 8), surgical palpation, along with intraoperative
ultrasonography (IOUS) findings, is regarded as the gold standard for the assessments
of accuracy in preoperative imaging modalities. However, this type of analysis does
not take into account any undetected liver metastases during surgery. True accuracy
can be assessed only after a sufficient amount of time has elapsed, in order to allow
the occult hepatic metastases to grow to a size sufficient for detection (9). 
MR imaging has been used increasingly for preoperative local staging of rectal
carcinomas (10-12). In our institution, unenhanced hepatic MR imaging is routinely
incorporated into a preoperative MR examination for the purpose of providing an all-
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in-one staging procedure. Using this protocol, contrast-
enhanced hepatic MR imaging, or IOUS, is performed only
when a hepatic resection is being considered based on the
findings of unenhanced hepatic MR imaging. IOUS has
been advocated as the most accurate method for the
diagnosis of liver metastasis (13-15). Furthermore, some
authors have advocated the routine use of IOUS for the
screening of liver metastases, even in patients with
negative findings on preoperative imaging studies (16, 17).
However, IOUS necessitates the wide surgical exposure of
the liver for accurate evaluation. Therefore, a preoperative
screening method with a high negative predictive value is
necessary to preclude unnecessary IOUS examinations.
Our anecdotal experience with negative findings on
preoperative MR imaging in patients who had undergone
curative surgery suggests that the incidence of hepatic
metastasis on follow-up CT is relatively low. 
Therefore, this study assessed the follow-up results after
negative findings on unenhanced hepatic MR imaging in
patients who had undergone curative surgery for rectal
carcinoma.
MATERIALS AND METHODS
Between February 1998 and March 2001, a total of 286
consecutive patients with histopathologically proven rectal
adenocarcinoma underwent preoperative MR imaging for
the local staging of tumors, as well as for the detection of
hepatic metastases.
One investigator (J.S.L.) reviewed all the pertinent
imaging reports and medical records. From these, we
selected 255 patients who had scored negative results on
unenhanced hepatic MR, excluding patients with lesions
reported as potentially representing hepatic metastasis on
preoperative MR reports (n = 31). In addition, the follow-
ing patients were excluded from the study: 1) patients in
whom the extrahepatic (n = 3, lung or retroperitoneal
lymph node) metastases were detected by preoperative
staging work-up (physical exam, measurement of
carcinoembryonic antigen, chest roentgenogram, and
MRI), 2) patients in whom the surgery was judged to be
non-curative (n = 13) due to peritoneal seeding or local
aggressiveness. These 16 patients were excluded from our
analysis because, although a hepatic metastasis may
develop in these patients on follow-up studies, it cannot be
determined that the patients harbored undetected occult
metastases (false negative) upon preoperative MR imaging.
The remaining 239 patients were considered for inclusion
in the study if they had the appropriate follow-up. Seven
patients were entirely lost to follow-up. Eighty-three
patients had postoperative CT follow-ups at less than 18
months, and were excluded as it was not appropriate to
dismiss the possibility of a very slowly growing metastasis
with this relatively short-term follow up period. The final
study group consisted of 149 patients. Ninety-seven men
and 52 women were included in the study, with a mean
age of 59.2 years (range, 22 to 85 years). In all cases,
surgery was performed by the same surgeon (N.K.K). The
surgeon intraoperatively palpated the liver in all patients.
The histological stages of the selected patients are shown in
Table 1, according to the TNM system. 
Preoperative Liver MR Imaging
The time interval between MR imaging and operation
was 1-34 days (mean, 8 days). The MR imaging was
performed with a 1.5-T MR scanner (Signa Horizon; GE
Medical Systems, Milwaukee, Wis). All images were
obtained in the axial plane, using a phased-array multicoil.
A rectangular field of view of 32×24-29×22 cm, which
was adjusted for each patient, was held constant for all
sequences. The MR imaging consisted of a) a respiratory-
triggered T2-weighted fast spin-echo (FSE) (effective TR
range/effective TE of 3500-10900/96-105, echo train
length of 8-16, two signal averages, a matrix of 256×
256, chemical shift fat suppression, superior and inferior
spatial pre-saturation, chemically selective fat saturation,
and a 7-8-mm slice thickness with a 1-2-mm gap), b) a
breath-hold T1-weighted fast multiplanar spoiled gradient
recalled-echo (GRE) in-phase (150-200/4.2-4.4, flip
angle of 90°, one signal acquired, a matrix of 256×128,
8-10-mm slice thickness, and zero gap, interleaved), and
c) a breath-hold T2-weighted single-shot half-Fourier
image (effective TE 180, a matrix of 256×160, and a 7-8-
mm slice thickness with a 1-2-mm gap). Contrast-
enhanced studies were performed only when a patient was
suspected of hepatic metastasis on the unenhanced studies,
and no such patients were included in this study.
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Table 1. Histologic Stages of the Selected Patients Group 
Stage Number of Patients
T1, N0 3 (2.0%)
T2, N0 31 (20.8%)
T3, N0 48 (32.2%)
T4, N0 1 (0.7%)
Less than T4, N1 6 (4.0%)
Less than T4, N2 60 (40.3%)
Note.─ Histologic stages are as follows: T1, limited to mucosa and
submucosa; T2, extension into but not through the muscularis propria; T3,
invasion of perirectal fat; T4, invasion of adjacent structures; N0, no
involved lymph nodes; N1, < four regional nodes positive for tumor; N2, >
four regional nodes positive for tumor.
Retrospective Analysis of Follow-up CT
Postoperative follow-up tests were routinely prescribed
for the first two years in our institution. These tests
included a physical examination, measurements of
carcinoembryonic antigen levels, liver function tests every
three months, and CT imaging every six months.
The CT scans were performed using a single-detector CT
(Somatom plus-S [Siemens, Erlangen], HiSpeed CT/I [GE
Medical Systems, Milwaukee, Wis]) or multidetector CT
(Lightspeed Plus [GE Medical Systems, Milwaukee, Wis])
with a contiguous 5-8 mm slice thickness and a pitch of
1-1.5. A 60% wt/vol contrast medium (approximately a
90% higher osmolarity, and 10% lower osmolarity agent)
was administered intravenously at a rate of 2-4 mL/sec,
using an automatic power injector with a volume of 2
mL/kg, up to a maximum volume of 150 ml. CT scans
were obtained approximately 70 seconds (parenchymal
phase) after the initiation of contrast material injection. 
The final diagnosis of the presence or absence of a liver
metastasis was made as follows: 1) When a new liver
tumor appeared on the follow-up CT, the final diagnosis of
the liver metastasis was made histologically via surgical
resection, clinically by typical appearance on the CT
and/or additional MR images, or the demonstration of
growth on the further follow-up CT, 2) The patients were
considered to be free of occult hepatic metastases if no
liver lesions had developed for at least 18 months after
surgery, 3) The final diagnosis of liver metastasis was based
on the latest imaging findings when a patient had died
during the follow-up period. In addition, the patients who
died without hepatic metastasis on follow-up CT after less
than 18 months were excluded, according to our patient
exclusion criteria (listed above). 
Metastatic lesions diagnosed during the follow-up period
were considered to be false-negative lesions on preopera-
tive MRI. The negative predictive value was defined as the
number of patients without metastases on the follow-up
CT, divided by the number of patients without metastases
on the preoperative MRI. However, in order to determine
that they were truly new or missed on the preoperative
MRI, the MR images were retrospectively reviewed, then
compared with the follow-up CT by consensus of the two
reviewers (J.S.L. and J.H.K.). Consensus was achieved
when both reviewers agreed that a metastatic nodule was
present or or absent on a preoperative MRI. 
RESULTS
Surgical and Clinical Follow-up Results
No unexpected hepatic metastases were found in any of
the patients included in the analysis by palpation. The
mean follow-up period was 29.4 months after surgery. The
median follow-up period was 29.3 months, and the longest
interval was 51.3 months. During the follow-up period,
106 (73%) patients received chemotherapy (n = 18) or
chemoradiation (n = 88). At the end of this study, 23
(15.4%) of the 149 patients developed recurrences of the
tumor (local recurrence without a remote recurrence in
four patients, remote recurrence without a local recurrence
in 16, and a remote and local recurrence in three patients).
There were 10 mortalities over the postoperative follow-
up period. Four patients died from causes not related to
rectal cancer. The spread of the rectal cancer constituted
the cause of death in the other 6 patients. The survival
rates were 98.7%, 95.6%, 91.8%, and 84.8%, with
follow-up times of 12, 24, 36, and 48 months (median,
29.3 months), respectively (Fig. 1).
Follow-up CT Results
Twenty-five hepatic metastatic lesions appeared during
the follow-up period in 13 patients (8.7%). The histologic
stages of those patients are as follows: Tumor invasion of
the muscularis propria without nodal metastasis in three
patients (T2, N0), tumor invasion into the perirectal tissues
without nodal metastasis in three patients (T3, N0), tumor
invasion into adjacent structures without nodal metastasis
(T4, N0) in one patient, one to three local lymph nodes
involved in one patients regardless of the depth of the
tumor invasion (Any T, N1), and four or more pericolic
lymph nodes involved in five patients, regardless of the
depth of the tumor invasion (Any T, N2). The interval
between surgery and the diagnosis of hepatic metastases
ranged from 2.6 to 28.2 months (mean: 11.6 months). The
tumors from 11 patients were detected before 18 months,
while the tumors from the remaining two patients were
detected after 21.3 months and 39 months, respectively.
Among the 13 patients, five exhibited solitary metastatic
tumors, while eight patients had multiple tumors at the
time of the initial diagnosis of the hepatic metastases: two
tumors in five patients, three tumors in two patients, and
four tumors in one patient. These 25 metastatic lesions
were not observed on the preoperative MR images in
consensus interpretation, retrospectively, although the
follow-up CT images were compared.
On the follow-up CT findings of the tumors in the 13
cases, 11 patients exhibited unequivocal findings of hepatic
metastasis. In two cases, small lesions of less than 1 cm
were judged to be metastatic lesions only after these
lesions showed growth on serial CT scans (Fig. 1).
Histologic confirmation was obtained by surgical resection
in four out of 13 patients. In the remaining patients, the
clinical diagnosis of hepatic metastasis was made according
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to serial CT findings (typical appearance of a metastatic
tumor or growth in size on the serial studies) as well as
laboratory findings, including elevations in carcinoembry-
onic antigen levels. The metastases in these 13 patients
were regarded to be present at the time of surgery, but
were not identified by preoperative MR images. Therefore,
the tumors in these 13 patients (8.7%) were judged to be
false negatives. The calculated negative predictive values
were 91.3% (136 out of 149 patients).
DISCUSSION
Intraoperative ultrasonography is believed to be the
most sensitive imaging technique for the detection of
hepatic metastases (13-15) . Conlon et al. suggested that
IOUS provides the most useful additional information with
regard to hepatic lesions, despite recent improvements in
preoperative MRI (18). However, in order to examine the
entire liver by IOUS, the liver needs to be mobilized, and
its diagnostic accuracy is then operator-dependent.
Therefore, the routine use of IOUS in all patients who
have undergone colorectal surgery is practically impossi-
ble. The goal of this study was to determine whether
noninvasive MR imaging could be used as a selective
method, to preclude unnecessary IOUS examinations. 
Some studies have reported false negative results from
Lim et al.
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A B
Fig. 1. A 43 year-old-woman with rectal cancer.
A, B. Preoperative MR images (T2-weighted single shot fast spin-echo image [17020/100] (A) and T1-weighted GRE image [230/4.0,
90°flip angle] (B)) show no evidence of metastasis in the liver.
C. Low attenuating subcentimetric lesion (white arrow) can be seen in the lateral segment on the follow-up CT scan, obtained three
months postoperatively. 
D. Growth of the lesion on the lateral segment (white arrow) can be seen on the CT scan at eight months postoperatively, which
represents a metastasis.
C D
IOUS on patients undergoing apparently curative surgeries
(8, 9, 19). Leen et al. (9) reported that 22 patients
developed overt liver metastases after a two-year follow-
up in 87 patients with negative findings on IOUS, in the
evaluation of hepatic metastasis (the negative predictive
value based on the follow-up result: 74.7%). The percent-
age of false negative IOUS results (number of patients with
metastasis on follow-up / number of patients with negative
findings on IOUS) was reported to be 9.0% (13/144) at 37
months by Machi et al. (8) and 13% (6/47) at 23 months
by Stone et al. (19). In this study, the overall false-negative
result for MR imaging was 8.7% after 29.4 months,
indicating an overall negative predictive value of 91.3%.
The negative predictive value for MR imaging in this study
was comparable to that obtained via IOUS.
Several limitations were inherent in this study. Although
newly discovered lesions on CT were defined as occult
metastases, other explanations might be adopted to
rationalize the existence of these lesions. The liver
metastases which were discovered later may have occurred
as the result of primary rectal cancer manipulation during
surgery. They might also have occurred postoperatively,
from primary cancer which had been partially left behind,
due to an incomplete resection. It is believed that these
possibilities were excluded due to our selection of only
those patients whose pathological specimens exhibited a
tumor-free resection margin. Secondly, advanced cases
which required treatment by postoperative chemotherapy
comprised the majority (115 patients [77%] were more
than T2N0) of this study. Among these advanced cases,
106 patients received postoperative adjuvant systemic
chemotherapy (71.1% among the 149 patients of the study
group). Therefore, the metastatic lesions could have been
eradicated, or at least suppressed, by the chemotherapy,
thereby resulting in higher negative predictive value for
the preoperative MR imaging. If there had been some
metastatic lesions which could have been eradicated by
chemotherapy, they might not need to have been resected
at the time of surgery. Therefore, this would not affect the
significance of the preoperative MR imaging. Thirdly, our
follow-up criteria (18 months) may have been insufficient
for the confirmation of the truly negative cases. It has been
reported that 80% of all recurrence develops during the
first two years after curative resection of colorectal cancer
(20, 21). Thus, it may be inappropriate to dismiss the
possibility of very slowly growing metastases within the
relatively short-term follow up period. More extended
follow-up results may be necessary to establish more
reasonable negative predictive values. Finally, no contrast
enhancement study was performed in this work. Other
studies have emphasized the importance of dynamic
gadolinium-enhanced MR for the characterization of focal
hepatic lesions (22-24). Several studies have also reported
that liver MRI using gadobenate dimeglumine or ferumox-
ides increased the detection of liver lesions, particularly in
cases of primary hepatic neoplasm (25, 26). However,
controversy remains with regard to the utility of gadolin-
ium-enhanced MR images for the improvement of the
detection rate of liver metastasis. In some studies, the
detection of non-hepatocellular carcinomas (including
metastases) did not increase due to the taking of dynamic
images (27, 28). Currently, tissue-specific contrast agents,
including superparamagnetic iron oxides and manganese
agents have been used to improve the detection of hepatic
metastases. However, the clinical indications for these
agents have not yet been established. These agents were
not available during the initial period of this study.
Currently, these agents are used when there is some
suspicion of a hepatic metastasis by sonography, CT, or
non-contrast enhanced MR imaging, as well as in cases in
which patients are eligible for hepatic resection.
In conclusion, this study demonstrated that preoperative
unenhanced MR imaging has a high negative predictive
value with regard to the detection of hepatic metastasis in
patients who have undergone curative surgery for rectal
cancer. The false-negative result was comparable to the
results reported for IOUS. Therefore, the routine use of
IOUS may not be warranted for those patients in whom
hepatic metastasis was not suspected, based on the
preoperative MR images.
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